Unknown

Dataset Information

0

?Np63 promotes pediatric neuroblastoma and osteosarcoma by regulating tumor angiogenesis.


ABSTRACT: The tumor suppressor gene p53 and its family members p63/p73 are critical determinants of tumorigenesis. ?Np63 is a splice variant of p63, which lacks the N-terminal transactivation domain. It is thought to antagonize p53-, p63-, and p73-dependent translation, thus blocking their tumor suppressor activity. In our studies of the pediatric solid tumors neuroblastoma and osteosarcoma, we find overexpression of ?Np63; however, there is no correlation of ?Np63 expression with p53 mutation status. Our data suggest that ?Np63 itself endows cells with a gain-of-function that leads to malignant transformation, a function independent of any p53 antagonism. Here, we demonstrate that ?Np63 overexpression, independent of p53, increases secretion of interleukin (IL)-6 and IL-8, leading to elevated phosphorylation of STAT3 (Tyr-705). We show that elevated phosphorylation of STAT3 leads to stabilization of hypoxia-inducible factor 1? (HIF-1?) protein, resulting in VEGF secretion. We also show human clinical data, which suggest a mechanistic role for ?Np63 in osteosarcoma metastasis. In summary, our studies reveal the mechanism by which ?Np63, as a master transcription factor, modulates tumor angiogenesis.

SUBMITTER: Bid HK 

PROVIDER: S-EPMC3950294 | biostudies-literature | 2014 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

ΔNp63 promotes pediatric neuroblastoma and osteosarcoma by regulating tumor angiogenesis.

Bid Hemant K HK   Roberts Ryan D RD   Cam Maren M   Audino Anthony A   Kurmasheva Raushan T RT   Lin Jiayuh J   Houghton Peter J PJ   Cam Hakan H  

Cancer research 20131023 1


The tumor suppressor gene p53 and its family members p63/p73 are critical determinants of tumorigenesis. ΔNp63 is a splice variant of p63, which lacks the N-terminal transactivation domain. It is thought to antagonize p53-, p63-, and p73-dependent translation, thus blocking their tumor suppressor activity. In our studies of the pediatric solid tumors neuroblastoma and osteosarcoma, we find overexpression of ΔNp63; however, there is no correlation of ΔNp63 expression with p53 mutation status. Our  ...[more]

Similar Datasets

| S-EPMC8202873 | biostudies-literature
| S-EPMC5363607 | biostudies-literature
| S-EPMC8529043 | biostudies-literature
| S-EPMC10931962 | biostudies-literature
| S-EPMC10903076 | biostudies-literature
| S-EPMC9798605 | biostudies-literature
| S-EPMC3527677 | biostudies-literature
| S-EPMC5244871 | biostudies-literature
| S-EPMC7234970 | biostudies-literature
| S-EPMC5574049 | biostudies-literature